214 related articles for article (PubMed ID: 2728396)
1. Erythroblastosis fetalis produced by anti-k.
Bowman JM; Harman FA; Manning CR; Pollock JM
Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
[TBL] [Abstract][Full Text] [Related]
2. Severe erythroblastosis fetalis secondary to anti-Kpb sensitization.
Dacus JV; Spinnato JA
Am J Obstet Gynecol; 1984 Dec; 150(7):888-9. PubMed ID: 6507516
[No Abstract] [Full Text] [Related]
3. Severe hemolytic disease of the newborn due to anti-Js(b).
Gordon MC; Kennedy MS; O'Shaughnessy RW; Waheed A
Vox Sang; 1995; 69(2):140-1. PubMed ID: 8585197
[TBL] [Abstract][Full Text] [Related]
4. Current clinical management of anti-Kell alloimmunization in pregnancy.
Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietic suppression in fetal anemia because of Kell alloimmunization.
Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM
Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708
[TBL] [Abstract][Full Text] [Related]
6. Haemolytic disease of the newborn due to anti-k.
Duguid JK; Bromilow IM
Vox Sang; 1990; 58(1):69. PubMed ID: 2316215
[No Abstract] [Full Text] [Related]
7. [Fetal death and benign hemolytic disease of the newborn from anti-Cellano alloimmunization: 2 new case reports].
Rigal D; Juron-Dupraz F; Biggio B; Jouvenceaux A
Rev Fr Transfus Immunohematol; 1982 Feb; 25(1):101-4. PubMed ID: 7071459
[TBL] [Abstract][Full Text] [Related]
8. [Kell antibodies in pregnancy].
Rempen A; Schweppe KW
Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
[TBL] [Abstract][Full Text] [Related]
9. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
Wenk RE; Goldstein P; Felix JK
Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
[TBL] [Abstract][Full Text] [Related]
10. The second example of anti-K22 and a family genetically informative for K and K22.
Manny N; Levene C; Harel N; Schneiderman S; Simon A; Daniels GL
Vox Sang; 1985; 49(2):135-7. PubMed ID: 4036083
[TBL] [Abstract][Full Text] [Related]
11. [Hemolytic disease of the newborn due to anti-Ku (author's transl)].
Huang HJ; Tagawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):119-21. PubMed ID: 7199551
[No Abstract] [Full Text] [Related]
12. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
[TBL] [Abstract][Full Text] [Related]
13. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
14. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
[TBL] [Abstract][Full Text] [Related]
15. Management of pregnancies complicated by anti-E alloimmunization.
Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
[TBL] [Abstract][Full Text] [Related]
16. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
[TBL] [Abstract][Full Text] [Related]
17. Haemolytic disease of the newborn because of rare anti-Vel.
van Gammeren AJ; Overbeeke MA; Idema RN; van Beek RH; Ten Kate-Booij MJ; Ermens AA
Transfus Med; 2008 Jun; 18(3):197-8. PubMed ID: 18598283
[TBL] [Abstract][Full Text] [Related]
18. [Hemolytic disease of the newborn due to Kell sensitization].
Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
[No Abstract] [Full Text] [Related]
19. Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands.
Luken JS; Folman CC; Lukens MV; Meekers JH; Ligthart PC; Schonewille H; Zwaginga JJ; Janssen MP; van der Schoot CE; van der Bom JG; de Haas M
Transfusion; 2021 Mar; 61(3):713-721. PubMed ID: 33528025
[TBL] [Abstract][Full Text] [Related]
20. [Kell alloimmunization in pregnancy].
Gariod S; Brossard Y; Poissonnier MH; Vuilliez B; Deutsch V; Jouk PS; Pons JC
J Gynecol Obstet Biol Reprod (Paris); 2004 Nov; 33(7):637-48. PubMed ID: 15550883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
